iZafe Group (IZAFE-B) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Jun, 2026Executive summary
Transitioned to a fully recurring revenue model, with Q4 net sales of 2,435 TSEK, all from license revenues, and no hardware sales compared to the prior year.
Annual recurring revenue (ARR) at the start of 2026 reached approximately 10 MSEK, meeting targets.
Expanded Nordic and European presence through new distribution agreements in Iceland and Norway, and consolidated Dutch operations.
Launched new modular external display and remote care system for Dosell after the quarter, enhancing product flexibility and scalability.
Financial highlights
Q4 net sales: 2,435 TSEK (2,345 TSEK in Q4 2024), entirely recurring license revenues.
Q4 EBIT: -5,714 TSEK (-5,679 TSEK in Q4 2024); Q4 EBITDA: -3,888 TSEK (-4,174 TSEK in Q4 2024).
Q4 net result: -4,857 TSEK (-5,908 TSEK in Q4 2024); EPS: -0.01 SEK (-0.02 SEK in Q4 2024).
Full-year net sales: 5,991 TSEK (7,954 TSEK in 2024), reflecting the shift to recurring revenues.
Cash flow from operating activities Q4: -2,940 TSEK (-178 TSEK in Q4 2024); cash and cash equivalents at period end: 1,673 TSEK.
Outlook and guidance
Entering 2026 with ARR of 10 MSEK and a stable, growing base.
Focus for 2026 on expanding customer base and increasing penetration among existing customers.
Ongoing ADDA procurement process in Sweden could further strengthen market position if successful.
Latest events from iZafe Group
- Recurring revenues and major contracts drive strong growth outlook, despite ongoing losses.IZAFE-B
Q1 202628 Apr 2026 - Recurring revenue model established, ARR at 10 MSEK, and Nordic expansion underway.IZAFE-B
Q3 202523 Apr 2026 - Recurring revenue model established, ARR quadrupled, and European expansion accelerates.IZAFE-B
Q3 20253 Nov 2025 - Recurring revenue growth and European expansion drive strong momentum in Q2 2025.IZAFE-B
Q2 202529 Aug 2025 - Revenue surged as Dosell expanded, with losses narrowing and growth momentum accelerating.IZAFE-B
Q3 202413 Jun 2025 - Net sales fell in Q2, but demand and new contracts signal growth ahead.IZAFE-B
Q2 202413 Jun 2025 - Recurring revenues and international expansion drive improved results and future growth.IZAFE-B
Q1 20256 Jun 2025 - Revenue doubled and ARR surged as iZafe accelerates international expansion.IZAFE-B
Q4 20245 Jun 2025